Cresset Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Cresset Asset Management’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-112,581	Closed	-$112K	–	1944
2023 Q3	$112K	Hold	112,581	–	–	﹤0.01%	1704
2023 Q2	$55.2K	Buy	+112,581	New	+$92.1K	﹤0.01%	1841
2021 Q3	–	Sell	-18,504	Closed	-$829K	–	1150
2021 Q2	$829K	Buy	18,504 +8,620	+87%	+$400K	0.01%	405
2021 Q1	$497K	Buy	+9,884	New	+$674K	0.01%	481

Cresset Asset Management's CELL Position: Q4 2023 in Review

Cresset Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 112,581 shares — an estimated $112K sold.

Cresset Asset Management first reported a position in CELL in Q1 2021 and held it in 4 quarters. The position peaked at $829K in Q2 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

Cresset Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Cresset Asset Management sold 112,581 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $112K.
Cresset Asset Management first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Cresset Asset Management's PhenomeX Inc. Common Stock position peaked at $829K in Q2 2021.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Cresset Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.